| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Blount Sally E. serves as a Director at ABT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 3 sells. Those positions are worth an estimated $239K at current prices.
The biggest single holding is ULTA (~$239K) as Director. The recent filings there lean toward selling, a net 65 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | ABT Abbott Laboratories | Director | Sell | 2,600 | $129.66 | $337,116.00 | -7.1% | -2.1% | - | |
| Jun 26, 2020 | ULTA Ulta Beauty, Inc. | Director | Buy | 250 | $193.00 | $48,250.00 | +25.3% | - | - | |
| Jul 31, 2019 | ABT Abbott Laboratories | Director | Sell | 2,500 | $87.65 | $219,120.50 | -8.7% | - | - | |
| Jun 21, 2019 | ULTA Ulta Beauty, Inc. | Director | Sell | 315 | $359.28 | $113,173.20 | -24.2% | - | - | |
| Nov 1, 2016 | ABT Abbott Laboratories | Director | Buy | 5,100 | $39.24 | $200,124.00 | +33.9% | - | - |